BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3035084)

  • 1. Effects of GABAergic drugs on the GABA turnover in the substantia nigra and the corpus striatum of the rat.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):33-46. PubMed ID: 3035084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro.
    Waldmeier PC; Wicki P; Feldtrauer JJ; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):289-95. PubMed ID: 2839779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the normal nerve impulse flow on the synthesis and utilization of GABA in the rat substantia nigra.
    Lindgren S; Andén NE
    J Neural Transm; 1985; 61(1-2):21-34. PubMed ID: 3981161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA(A) receptors in the pars compacta and GABA(B) receptors in the pars reticulata of rat substantia nigra modulate the striatal dopamine release.
    Balon N; Kriem B; Weiss M; Rostain JC
    Neurochem Res; 2002 May; 27(5):373-9. PubMed ID: 12064352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-aminobutyric acid (GABAB) receptor-mediated inhibition of tyrosine hydroxylase activity in the striatum of rat.
    Arias-Montaño JA; Martínez-Fong D; Aceves J
    Neuropharmacology; 1991 Oct; 30(10):1047-51. PubMed ID: 1684645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):47-57. PubMed ID: 3585320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic modulation of the release of GABA by GABAA receptors in pars compacta and by GABAB receptors in pars reticulata of the rat substantia nigra.
    Floran B; Silva I; Nava C; Aceves J
    Eur J Pharmacol; 1988 Jun; 150(3):277-86. PubMed ID: 2843383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicuculline insensitive effects of baclofen.
    Rägo LK; Zarkovsky AM
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):166-9. PubMed ID: 6306483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines.
    Agmo A; Pruneda R; Guzmán M; Gutiérrez M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):314-22. PubMed ID: 1660103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical antagonism by bicuculline of the inhibition by baclofen of the electrically evoked release of [3H]GABA from rat cerebral cortex slices.
    Maurin Y
    Eur J Pharmacol; 1988 Oct; 155(3):219-27. PubMed ID: 2853062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-injurious behavior in rats produced by intranigral microinjection of GABA agonists.
    Baumeister AA; Frye GD
    Pharmacol Biochem Behav; 1984 Jul; 21(1):89-95. PubMed ID: 6540454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA terminal autoreceptors in the pars compacta and in the pars reticulata of the rat substantia nigra are GABAB.
    Giralt MT; Bonanno G; Raiteri M
    Eur J Pharmacol; 1990 Jan; 175(2):137-44. PubMed ID: 2155793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of endogenous GABA from the substantia nigra is not controlled by GABA autoreceptors.
    Waldmeier PC; Wicki P; Feldtrauer JJ; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):372-8. PubMed ID: 2555718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of KCl-induced depolarization on the GABA concentration in the corpus striatum and in the substantia nigra.
    Lindgren S
    J Neural Transm; 1986; 66(3-4):161-70. PubMed ID: 3783143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of acetylcholine release from rat striatal slices by the GABA/benzodiazepine receptor complex.
    Supavilai P; Karobath M
    Life Sci; 1985 Feb; 36(5):417-26. PubMed ID: 2982067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional differences in the changes in rat brain GABA concentrations post mortem and following inhibition of the synthesis and metabolism.
    Andén NE; Lindgren S; Magnusson A
    Pharmacol Toxicol; 1987 May; 60(5):393-6. PubMed ID: 3615349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential role of GABAA and GABAB receptors in two distinct output stations of the rat striatum: studies on the substantia nigra pars reticulata and the globus pallidus.
    Ikeda H; Kotani A; Koshikawa N; Cools AR
    Neuroscience; 2010 Apr; 167(1):31-9. PubMed ID: 20132872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of GABA receptors in the control of nigrostriatal dopaminergic neurons: dual-probe microdialysis study in awake rats.
    Santiago M; Westerink BH
    Eur J Pharmacol; 1992 Aug; 219(2):175-81. PubMed ID: 1330605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The locomotor-reducing effects of GABAergic drugs do not depend on the GABAA receptor.
    Agmo A; Giordano M
    Psychopharmacology (Berl); 1985; 87(1):51-4. PubMed ID: 2997828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.